Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
about
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsSalutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.Mechanisms of dyslipidemia of chronic renal failure.Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.The genetics of neutral lipid biosynthesis: an evolutionary perspectiveCauses of dysregulation of lipid metabolism in chronic renal failure.HDL metabolism and activity in chronic kidney disease.Statins in the management of dyslipidemia associated with chronic kidney disease.Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.HDL abnormalities in nephrotic syndrome and chronic kidney disease.Worsening of lipid metabolism after successful treatment of primary aldosteronism.ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.Increased calcium intake reduces plasma cholesterol and improves vasorelaxation in experimental renal failure.Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.The time-dependent effect of gluconasturtiin and phenethyl isothiocyanate on metabolic and antioxidative parameters in rats.Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
P2860
Q28074264-0D20207A-13D9-447A-A54E-B8887796EB6DQ35747579-8AD6F556-3380-4F43-9DEC-F741069618EEQ36364965-244E7401-6632-4C70-8ABA-9B761A0F7B35Q36379589-DFBCE3B0-41E5-41F0-89A0-F98F81C32DE3Q36721867-1C2E8B67-5DD2-41FA-BBAC-74016FC9F675Q37264190-9EDF3DCF-CCB6-4875-ADB7-C22BEF77438DQ37657707-A14653D5-B795-4BF9-8F7C-4B34C7E01CAFQ37716581-BD1D8DFE-A9D1-4B65-9A0C-B5EFBB8854DAQ37986355-A0C7FBD0-E9A4-457C-B331-C295B5D66FD0Q38076217-FB6D1A77-B705-45E0-A08B-ED601EE5F1D5Q38131300-933146CF-2709-4317-BC26-A418E29D47D2Q38633497-5428E742-B2B3-4691-BE4C-53409978CE8AQ39766085-DC0FFB27-8506-4C16-A44B-6E1CE2891AB2Q40492904-33118CF2-A780-4F52-8741-884696F5D9A4Q40587729-B8A16839-F338-46EE-B2E5-E9A84BE4FC96Q43247391-455BE75E-C0E3-4816-A99B-2C835426DC4EQ44619347-8EED1C78-C388-49E0-A543-9D90B293850AQ44792821-0972C475-15BD-401E-8F9D-66D20EA43CCBQ45126783-9410A491-5EF5-45AE-8175-B572F5B9B73FQ45176893-9A8E1FB5-D61A-46DB-B091-41297FC08259Q46885760-9AE905BB-6CC5-4806-8AD4-1B86F88DCD30Q47378700-7B3F0E19-80B9-471B-A4A4-787408FFC758
P2860
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
scientific journal article
@en
vedecký článok (publikovaný 2002/10/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/01)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
مقالة علمية (نشرت في أكتوبر 2002)
@ar
name
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@ast
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@en
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@nl
type
label
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@ast
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@en
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@nl
prefLabel
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@ast
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@en
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@nl
P2860
P1476
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure
@en
P2093
Kaihui Liang
N. D. Vaziri
P2860
P304
P356
10.1152/AJPENDO.00364.2001
P577
2002-10-01T00:00:00Z